Evidence map›Paper›PMID 28588064›Full record

ArticleThe EMBO journal2017

Autotaxin-lysophosphatidic acid-LPA

Shizu Aikawa, Kuniyuki Kano, Asuka Inoue, Jiao Wang, Daisuke Saigusa, Takeshi Nagamatsu, Yasushi Hirota, Tomoyuki Fujii, Soken Tsuchiya, Yoshitaka Taketomi and 8 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Primary cilia and their role in preeclampsia.International journal of medical sciences · 2025
    Review
  8. Article
  9. Review
  10. Autotaxin Expression in the Uterus of Cycling Rats.Development & reproduction · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Lysophosphatidic acid stimulates rat uterine contraction in vitro.The Journal of reproduction and development · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Lysophospholipid Mediators in Health and Disease.Annual review of pathology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 2 countries.

Shizu AikawaGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.
Kuniyuki KanoGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.
Asuka InoueGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.
Jiao WangGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.
Daisuke SaigusaJapan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan.
Takeshi NagamatsuDepartment of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.ORCID 0000-0003-1480-5785
Yasushi HirotaDepartment of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.ORCID 0000-0003-0241-9780
Tomoyuki FujiiDepartment of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Soken TsuchiyaDepartment of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
Yoshitaka TaketomiTokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, Japan.
Yukihiko SugimotoJapan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan.
Makoto MurakamiJapan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan.
Makoto AritaRIKEN, Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
Makoto KuranoJapan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan.
Hitoshi IkedaJapan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan.
Yutaka YatomiJapan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan.
Jerold ChunSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Junken AokiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan jaoki@m.tohoku.ac.jp.ORCID 0000-0001-9435-1896
Tohoku University · JPJapan Agency for Medical Research and Development · JPThe University of Tokyo · JPKeio University · JPKumamoto University · JPSanford Burnham Prebys Medical Discovery Institute · USTokyo Metropolitan Institute of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During pregnancy, up-regulation of heparin-binding (HB-) EGF and cyclooxygenase-2 (COX-2) in the uterine epithelium contributes to decidualization, a series of uterine morphological changes required for placental formation and fetal development. Here, we report a key role for the lipid mediator lysophosphatidic acid (LPA) in decidualization, acting through its G-protein-coupled receptor LPA

Indexed as

Signal TransductionAnimalsCyclooxygenase 2DeciduaEmbryo, MammalianEmbryonic DevelopmentFemaleGene Knockout TechniquesHeparin-binding EGF-like Growth FactorLysophospholipase DLysophospholipidsMiceMice, KnockoutPhosphoric Diester HydrolasesReceptors, Lysophosphatidic AcidUterusCyclooxygenase 2Hbegf protein, mouseHeparin-binding EGF-like Growth FactorLpar3 protein, mouselysophosphatidic acidLysophospholipase DLysophospholipidsPhosphoric Diester HydrolasesPtgs2 protein, mouseReceptors, Lysophosphatidic Acidautotaxindecidualizationembryo implantationLPA 3lysophosphatidic acid

Identifiers

PMID28588064
PMCPMC5509998
OpenAlexW2622468223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.